2023 Specialty Day Access Pass-Subacromial Balloon Spacer

Video Transcription

Video Summary

Dr. Joe Boot discusses the subacromial balloon spacer, used since FDA approval in 2021 for massive irreparable rotator cuff tears with specific indications. His experience includes 58 cases post-approval and positive outcomes such as improved forward elevation (by 27-37 degrees), ASES scores, and pain reduction over up to six years. He stresses correct patient selection, early deltoid-focused rehab, and acknowledges a rehab dip around three months. The procedure is safe, minimally invasive, with quick recovery, and has evolving economic viability. Repeat balloon placement showed sustained benefit. Overall, it offers pain relief, function improvement, and does not limit future surgeries.

Asset Caption

Joseph A. Abboud, M.D.

Keywords

subacromial balloon spacer

massive irreparable rotator cuff tears

FDA approval 2021

patient selection and rehab

long-term outcomes and safety